News

Filter

Current filters:

IpsenGastro-intestinals

PeptiDream and Ipsen expand their peptide drug collaboration to treat endocrinologic disease

07-10-2013

PeptiDream and Ipsen have expanded the scope of their April 2013 research collaboration and license option…

Asia-PacificGastro-intestinalsIpsenLicensingPeptiDreamPharmaceutical

Launch of Ipsen/Braintree's Eziclen/Izinova in Europe expected by end 2013

07-02-2013

French drugmaker Ipsen (Euronext: IPN) and US partner Braintree Laboratories yesterday announced today…

Braintree LaboratoriesEuropeEziclenGastro-intestinalsIpsenIzinovaPharmaceuticalRegulation

Rhythm expands Series B financing to $33 Million, adding Pfizer Ventures as an investor

27-11-2012

Boston, USA-based biotech firm Rhythm Pharmaceuticals says it has raised an additional $8 million to…

BiotechnologyFinancialGastro-intestinalsIpsenPfizerResearchRhythm PharmaceuticalsRM-131

COMPANY SPOTLIGHT

Menarini

Back to top